Atlas Trials

Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

Clinical trial NCT05638880 · COMPLETED

Trial details

NCT number
NCT05638880
Sponsor
Mostafa Bahaa
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Nephropathies
Start date
2022-12-20
Primary completion
2025-12-20
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.